Thu.Jan 16, 2025

article thumbnail

India’s life sciences sector: A vision for budget FY2025

Express Pharma

Hitesh Sharma, Partner and Life Sciences Leader Tax, EY India As India’s life sciences sector enters FY 2025, its innovation-driven growth and resilience call for supportive government reforms to sustain momentum and strengthen global leadership. Aligned with the ‘Atmanirbhar Bharat’ vision, the sector seeks targeted initiatives to achieve its $130 billion goal by 2030.

105
105
article thumbnail

By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years

PharmaVoice

The J.P. Morgan Healthcare Conference has been a focal point for M&A year after year, and after a quiet period, the deals are back on the table.

186
186
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

‘The bar has risen’: China’s biotech gains push US companies to adapt

BioPharma Dive

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors and executives interviewed by BioPharma Dive at the J.P. Morgan Healthcare Conference.

144
144
article thumbnail

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials

Pharma Times

New partnership to advance precision medicine in lung cancer diagnosis

136
136
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab

Express Pharma

AstraZeneca Pharma India announces a Central Drugs Standard Control Organisation (CDSCO) permission to import, sell or distribute Eculizumab concentrate solution for infusion 300 mg (10mg/ml). Eculizumab is an anti-complement medical therapy indicated for treating two rare conditions- Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Hemolytic Uremic Syndrome (aHUS), both in children and adults.

59

More Trending

article thumbnail

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

BioPharma Dive

AbbVie's CEO hinted his company may be less willing to invest in psychiatry after a costly setback, while Lilly explained what it got wrong forecasting GLP-1 drug demand.

122
122
article thumbnail

HPM Grows Its Ranks of Directors, Counsel, and Associates as it begins its 45th Anniversary Year

FDA Law Blog: Biosimilars

Hyman, Phelps & McNamara PC, (HPM), which will mark its 45thAnniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. Kalie E. Richardson has been promoted to Director. Mark Tobolowsky has been promoted to Counsel; and Esther Petrikovsky is joining the firm as an Associate.

article thumbnail

Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world

BioPharma Dive

Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his team of dealmakers can juggle them.

122
122
article thumbnail

Pharmacy Staffing Trend Predictions for 2025

The Script

What staffing trends can we expect to see in 2025? Our team at Rx relief breaks down a few upcoming trends in pharmacy staffing.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Lilly gains US FDA approval for Omvoh to treat Crohn’s disease

Pharmaceutical Technology

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult population.

105
105
article thumbnail

Bioptimus raises $41m for its GenAI model for biology

pharmaphorum

AI start-up Bioptimus takes its funding above $76m as it prepares for the launch of a universal foundation model for pathology later this year.

105
105
article thumbnail

JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecast

Pharmaceutical Technology

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

105
105
article thumbnail

Lilly nets a second FDA okay for Omvoh, in Crohn's disease

pharmaphorum

Eli Lilly picks up a second FDA approval for IL-23 inhibitor Omvoh in Crohn's disease, but will it kickstart sales growth

104
104
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

“Nothing to do with geopolitics”: WuXi Biologics CEO bullish in face of Biosecure

Pharmaceutical Technology

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling effect on clients.

105
105
article thumbnail

FDA bans red dye used in medicines over cancer risk

pharmaphorum

The FDA has banned the use of a red dye used in oral medicines, foods, and dietary supplements, more than 30 years after it was linked to cancer.

98
article thumbnail

Driving innovation in clinical trials: Patient perspectives and multidimensional assessments

Outsourcing Pharma

Driving Innovation in Clinical Trials: Patient Perspectives and Multidimensional Assessments

93
article thumbnail

Santhera preps UK Duchenne drug launch after NICE says yes

pharmaphorum

Santhera will launch its new drug for Duchenne muscular dystrophy in the UK within the next few weeks after getting the green light for NHS coverage

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Overcoming clinical trial obstacles with AI: WCG’s outlook for SCOPE 2025

Outsourcing Pharma

Explore WCG's cutting-edge AI and tech solutions, including ClinSphere Total Enrollment, transforming clinical trials at SCOPE 2025.

89
article thumbnail

Life Sciences Industry Report – Part 3

pharmaphorum

Across every corner of the industry, from research and development to patient engagement, AI, and most recently generative AI (GenAI), is driving profound change.

90
article thumbnail

AI-designed proteins neutralize snake toxins

World Pharma News

A new study in Nature by last year's Nobel Laureate in Chemistry reveals a possible game-changer in snakebite treatment. Researchers have created new proteins that neutralise lethal toxins found in snake venom, potentially offering a safer and more effective alternative to traditional antivenoms.

83
article thumbnail

Decentralized clinical trials take the spotlight at SCOPE 2025

Outsourcing Pharma

Discover Medable's latest advancements in decentralized clinical trials, including AI-driven tools and enhanced eCOA solutions, at SCOPE 2025.

78
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Speedier drug trials and better films: how AI is transforming businesses

The Guardian - Pharmaceutical Industry

From aviation to retail, many industries are already looking to artificial intelligence to improve productivity Keir Starmer this week announced a 50-point plan that aims to give the UK world leader status in artificial intelligence and grow the economy by as much as 47bn a year over a decade. The multibillion-pound investment , which seeks to create a 20-fold increase in the amount of AI computing power under public control by 2030, has been framed as a gamechanger for businesses and public org

76
article thumbnail

J&J files intravesical bladder cancer drug TAR-200 in US

pharmaphorum

Johnson & Johnson has started a marketing application in the US for TAR-200 as a treatment for non-muscle-invasive bladder cancer (NMIBC).

75
article thumbnail

Lilly’s Omvoh approved by FDA for Crohn’s

BioPharma Dive

The clearance broadens use of Omvoh, which is part of a slate of new medicines Lilly is counting on to build on its success in diabetes and obesity.

article thumbnail

FTC Report Finds Big Three PBM Mark Ups for Specialty Generics Generated Billions

Pharmaceutical Commerce

CVS Caremark, Express Scripts, OptumRx made more than $7.3 billion in revenue, with markups as high as thousands of percent.

64
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.